This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Mar 24;323(12):1184-1185.

doi: 10.1001/jama.2020.1176.

When Can Intermediate Outcomes Be Used as Surrogate Outcomes?

David L DeMets¹, Bruce M Psaty², Thomas R Fleming³

Affiliations

Affiliations

¹ Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison.
² Department of Medicine and Epidemiology, University of Washington, Seattle.
³ Department of Biostatistics, University of Washington, Seattle.

PMID: 32105291
DOI: 10.1001/jama.2020.1176

Comment

When Can Intermediate Outcomes Be Used as Surrogate Outcomes?

David L DeMets et al. JAMA. 2020.

. 2020 Mar 24;323(12):1184-1185.

doi: 10.1001/jama.2020.1176.

Authors

David L DeMets¹, Bruce M Psaty², Thomas R Fleming³

Affiliations

¹ Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison.
² Department of Medicine and Epidemiology, University of Washington, Seattle.
³ Department of Biostatistics, University of Washington, Seattle.

PMID: 32105291
DOI: 10.1001/jama.2020.1176

No abstract available

PubMed Disclaimer

Comment on

Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers: A Systematic Review and Meta-analysis.
Ritchie G, Gasper H, Man J, Lord S, Marschner I, Friedlander M, Lee CK. Ritchie G, et al. JAMA Oncol. 2018 Apr 1;4(4):522-528. doi: 10.1001/jamaoncol.2017.5236. JAMA Oncol. 2018. PMID: 29470579 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information